Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Next Interface guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS You Might Also Like Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (September 2024) Introduction to the RUNX1-FPD Sirolimus Pilot Study (6.24.24) Revealing the Genetic Underpinnings of Cytopenias: Navigating the Path to Genetic Testing Hereditary Hematologic Malignancies: Not That Rare Module 4: Banking Stem Cells Today for the Possible Gene Editing Capabilities of Tomorrow
Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Next Interface guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS You Might Also Like Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (September 2024) Introduction to the RUNX1-FPD Sirolimus Pilot Study (6.24.24) Revealing the Genetic Underpinnings of Cytopenias: Navigating the Path to Genetic Testing Hereditary Hematologic Malignancies: Not That Rare Module 4: Banking Stem Cells Today for the Possible Gene Editing Capabilities of Tomorrow
